Default

Pharma Marketing Blog

AstraZeneca's Timely CRESTOR Branded Blog Post: Did It Violate Its Own Policy?

Lipitor R.I.P. Infographic

Pfizer Throws In the Lipitor Marketing Towel. Repercussions in Job Market Will Be Swift

Have You Met Turbo & Scott? FTC May Want to Meet this eBook for Children Sponsored by Novartis

Is 38 Hours Quick Enough to Respond to a Potentially Serious AE Tweet?

Obama's Executive Order Spurs Drug Industry to Cooperate with FDA to Ease Drug Shortages

Pharma Support of CME Infographic

Pfizer's Lipitor Co-pay Card/PBM Discount Plan Fails

Type 2 Diabetes in Obese Children Proves Difficult to Treat with Drugs Alone

Resurgence of Pharma Lobbying Spending

Novo Nordisk is Back on Pinterest with Patient Stories

Device Makers, e.g. Johnson & Johnson, May Benefit Most from FDA User Fee Bill

As Pharma Spends More on Digital, External Digital Agencies Receive Poor Ratings from Marketing Executives

Janssen Uses Digital Storytelling, Animation to "Bring Prescription Medicine Labeling to Life." But Not iPhone or iPad Life!

New Victoza Prescriptions Flatten After Novo Signs Deal with Paula Deen

Consumer Use of Social Media for Healthcare Purposes: Pharma Shouldn't "Drink the Kool-aid"!

Will J&J's Gorsky Plead the 5th? Or Send a Minion to Testify Like Bill Weldon?

Miami Beach Is Loco 4 Pharmaguy! Meet Me There This Thursday!

Beware of Subtle Changes to Social Media Sites that Can Impact Your Brand; e.g., Novo's Levemir

Lipitor Holds Key to DTC Ad Spending in 2012